Rosiglitazone improves insulin sensitivity by increasing plasma adiponectin and decreasing plasma resistin, and by reducing abdominal visceral adipose tissue in type 2 diabetic patients

被引：0
|
作者：
Cho, MH
Nam, JY
Song, YD
Kim, HJ
Kim, CS
Ahn, CW
Cha, BS
Yoo, JM
Lim, SK
Kim, KR
Lee, HC
机构：
来源：
DIABETES | 2005年 / 54卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A527 / A527
页数：1
相关论文
共 50 条
  • [1] Rosiglitazone improves insulin sensitivity by increasing plasma adiponectin and decreasing plasma resistin, and by reducing abdominal visceral adipose tissue in type 2 diabetic patients
    Nam, JY
    Kim, DM
    Park, JS
    Ahn, CW
    Kim, KR
    OBESITY RESEARCH, 2004, 12 : A42 - A42
  • [2] Adiponectin decreases plasma glucose and improves insulin sensitivity in diabetic swine
    Hu, Xiaobo
    She, Meihua
    Hou, Hongjie
    Li, Qinkai
    Shen, Qingyun
    Luo, Yi
    Yin, Weidong
    ACTA BIOCHIMICA ET BIOPHYSICA SINICA, 2007, 39 (02) : 131 - 136
  • [3] Adiponectin Decreases Plasma Glucose and Improves Insulin Sensitivity in Diabetic Swine
    Xiaobo HU
    Meihua SHE
    Hongjie HOU
    Qinkai LI
    Qingyun SHEN
    Yi LUO
    and Weidong YIN Department of Biochemistry and Biotechnology
    Acta Biochimica et Biophysica Sinica, 2007, (02) : 131 - 136
  • [4] Correlation of plasma resistin with obesity and insulin resistance in type 2 diabetic patients
    Gharibeh, M. Y.
    Al Tawallbeh, G. M.
    Abboud, M. M.
    Radaideh, A.
    Alhader, A. A.
    Khabour, O. F.
    DIABETES & METABOLISM, 2010, 36 (06) : 443 - 449
  • [5] Effect of rosiglitazone on insulin sensitivity, liver fat content C-reactive protein and plasma adiponectin in patients with Thai type 2 diabetic subjects
    Pratipanawatr, T
    Mailaing, E
    Pratipanawat, W
    DIABETES, 2004, 53 : A556 - A556
  • [6] Plasma concentrations of resistin in type 2 diabetic patients
    Hasegawa, G
    Ohta, M
    Shigeta, H
    Shigeta, M
    Tanaka, T
    Yamaguchi, M
    Obayashi, H
    Yamasaki, M
    Fukui, M
    Nakamura, N
    Yoshikawa, T
    DIABETES, 2003, 52 : A82 - A83
  • [7] Changes in adiponectin receptor expression in muscle and adipose tissue of type 2 diabetic patients during rosiglitazone therapy
    Tan, GD
    Debard, C
    Funahashi, T
    Humphreys, SM
    Matsuzawa, Y
    Frayn, KN
    Karpe, F
    Vidal, H
    DIABETOLOGIA, 2005, 48 (08) : 1585 - 1589
  • [8] Changes in adiponectin receptor expression in muscle and adipose tissue of type 2 diabetic patients during rosiglitazone therapy
    G. D. Tan
    C. Debard
    T. Funahashi
    S. M. Humphreys
    Y. Matsuzawa
    K. N. Frayn
    F. Karpe
    H. Vidal
    Diabetologia, 2005, 48 : 1585 - 1589
  • [9] Rosiglitazone improves insulin receptor signaling and peripheral insulin resistance in association with increased adiponectin level in type 2 diabetic patients
    Miyazaki, Yoshinori
    Mandarino, Lawrence J.
    Defronzo, Ralph A.
    DIABETES, 2006, 55 : A126 - A126
  • [10] Rosiglitazone is superior to glyburide in reducing pasting plasma glucose in type 2 diabetic patients.
    Lönnqvist, F
    Charbonnel, B
    Jones, NP
    Abel, MG
    Patwardhan, R
    DIABETOLOGIA, 1999, 42 : A231 - A231
12345